CEDAR KNOLLS, N.J., Dec. 1, 2008 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (NasdaqCM:EMIS - News), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its Eligen(r) Technology, today announced that Michael V. Novinski, President and Chief Executive Officer, will present on December 2, 2008 at the New York Society of Security Analysts (NYSSA) 12th Annual Biotech and Specialty Pharma Conference, 1177 Avenue of the Americas, 2nd Floor, New York, New York. Mr. Novinski's presentation will take place at 11:30 AM EST.
